Is Bristol-Myers Squibb into self-sabotage? Is Congress coming for Gut Guy? And why does Goldman Sachs love money so much?
We delve into all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Stay tuned for a discussion of the battle for dominance in lung cancer, the curious case of a confusing drug price, and multiple utterances of the phrase “vampire squid.” Also Adam Feuerstein is not on the show because he’s busy breaking his promise to abstain from Twitter while on vacation.
For more on the topics we cover, here’s the lung cancer story; here’s some background on pharma’s fear of an ad crackdown; and here’s a write-up of the Goldman note. Oh and here’s the origin of that whole “vampire squid” thing.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
